-A federal judge in Texas has rejected a bid by compounding pharmacies to allow them to continue making copies of Novo ...

'Ozempic Penis' is the new side-effect that people have been turning their heads at, and users are reporting experiencing ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Indian pharmaceutical companies are preparing to flood the market with generic versions of Novo Nordisk’s semaglutide—sold ...

Novo Nordisk, the maker of Ozempic and Wegovy, is predicted to lose billions in profits due to a minor billing error in ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

NVO jumps nearly 6% in a week on amycretin pipeline boost and hedge fund interest, but competition looms large.

Energy prices have jumped since the onset of clashes between Israel and Iran. Investors worry the conflict could have a big ...

We have recently begun acquiring a new position in Novo Nordisk. Click here for our investment thesis on NVO stock.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Novo Nordisk has rebounded strongly in 2025, backed by solid financials despite earlier setbacks and competitive risks. See ...

Some hairstylists have confirmed an uptick in clients who complain about losing hair while on weight-loss journeys.